193 related articles for article (PubMed ID: 10196694)
1. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs.
Zhao Q; Hay N; Morales CR
Mol Reprod Dev; 1997 Sep; 48(1):1-8. PubMed ID: 9266755
[TBL] [Abstract][Full Text] [Related]
4. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
[TBL] [Abstract][Full Text] [Related]
5. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
[TBL] [Abstract][Full Text] [Related]
6. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
7. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
Zhao Q; Bell AW; El-Alfy M; Morales CR
J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recombinant human saposin A expressed by Pichia pastoris.
Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
11. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
12. [Saposin B deficiency].
Kotani Y; Sano A
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):417-9. PubMed ID: 9645097
[No Abstract] [Full Text] [Related]
13. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
[TBL] [Abstract][Full Text] [Related]
14. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
15. Advances in the molecular genetics of metachromatic leukodystrophy.
Gieselmann V; von Figura K
J Inherit Metab Dis; 1990; 13(4):560-71. PubMed ID: 1977956
[TBL] [Abstract][Full Text] [Related]
16. [Saposin C deficiency].
Sano A
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):420-2. PubMed ID: 9645098
[No Abstract] [Full Text] [Related]
17. Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.
Kuchar L; Ledvinová J; Hrebícek M; Mysková H; Dvoráková L; Berná L; Chrastina P; Asfaw B; Elleder M; Petermöller M; Mayrhofer H; Staudt M; Krägeloh-Mann I; Paton BC; Harzer K
Am J Med Genet A; 2009 Feb; 149A(4):613-21. PubMed ID: 19267410
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
[TBL] [Abstract][Full Text] [Related]
19. [Deficiency of arylsulfatase A activity as a basis of metachromatic leucodystrophy].
Lugowska A; Tylki-Szymańska A
Postepy Biochem; 1996; 42(3):284-9. PubMed ID: 9036380
[No Abstract] [Full Text] [Related]
20. Sphingolipid activator protein B deficiency: report of 9 Saudi patients and review of the literature.
Al-Hassnan ZN; Al Dhalaan H; Patay Z; Faqeih E; Al-Owain M; Al-Duraihem A; Faiyaz-Ul-Haque M
J Child Neurol; 2009 Dec; 24(12):1513-9. PubMed ID: 19955343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
